Skip to content
naulon

Not checkedNot checked for notices yet.

Dosis aplicadas contra COVID-19 por laboratorio en las entidades territoriales de Colombia

Jorge Enrique Díaz Pinzón

Repertorio de Medicina y Cirugía · 2021

doi:10.31260/repertmedcir.01217372.1278 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Introduction: mass vaccination campaigns to prevent coronavirus 19 disease (COVID 19) are being conducted in many countries; there is urgency of providing estimates on vaccine efficacy to support decision-making. Objective: to present the progression of completed vaccination schedules by type of vaccine in the different territorial entities in Colombia as of August 24 2021. Methodology: a cross-sectional study specifically designed to gather information on various pharmaceutical company vaccines administered in Colombia; data was obtained from the Ministry of Health and Social Protection webpage based on the COVID 19 national vaccination plan. Results: the territorial entities with the most completed schedules administered by type of vaccine were: Bogotá (4’259.615), Antioquia (2’864.061), Valle del Cauca (2’004.655), Santander (1’289.588) and Cundinamarca (840.967), and those with the least were: Vichada (12.784), Vaupes (13.754), Guainía (20.706), Guaviare (31.598) and Amazonas (54.385). Conclusion: the deployment of vaccines against COVID-19 in Colombia offers a solution to mitigate the effects of the pandemic, but also poses challenges. Colombia is committed to guarantee that everyone in the country has fair and equitable access to COVID 19 vaccines.

Abstract licence: CC BY-NC-SA

References13

  1. 9.

12 more references, whose wording the paper’s licence keeps private.

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.